Cargando…
Dyskeratosis congenita and the DNA damage response
Dyskeratosis congenita (DC) is a heterogeneous bone marrow failure disorder with known mutations in components of telomerase and telomere shelterin. Recent work in a mouse model with a dyskerin mutation has implicated an increased DNA damage response as part of the cellular pathology, while mouse mo...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328754/ https://www.ncbi.nlm.nih.gov/pubmed/21477209 http://dx.doi.org/10.1111/j.1365-2141.2011.08679.x |
_version_ | 1782229769167831040 |
---|---|
author | Kirwan, Michael Beswick, Richard Walne, Amanda J Hossain, Upal Casimir, Colin Vulliamy, Tom Dokal, Inderjeet |
author_facet | Kirwan, Michael Beswick, Richard Walne, Amanda J Hossain, Upal Casimir, Colin Vulliamy, Tom Dokal, Inderjeet |
author_sort | Kirwan, Michael |
collection | PubMed |
description | Dyskeratosis congenita (DC) is a heterogeneous bone marrow failure disorder with known mutations in components of telomerase and telomere shelterin. Recent work in a mouse model with a dyskerin mutation has implicated an increased DNA damage response as part of the cellular pathology, while mouse models with Terc and Tert mutations displayed a normal response. To clarify how these contradictory results might apply to DC pathology in humans, we studied the cellular phenotype in primary cells from DC patients of several genetic subtypes, focussing on T lymphocytes to remain close to the haematopoietic system. We observed novel cell cycle abnormalities in conjunction with impaired growth and an increase in apoptosis. Using flow cytometry and confocal microscopy we examined induction of the DNA damage proteins γ-H2AX and 53BP1 and the cell cycle protein TP53 (p53). We found an increase in damage foci at telomeres in lymphocytes and an increase in the basal level of DNA damage in fibroblasts, but crucially no increased response to DNA damaging agents in either cell type. As the response to induced DNA damage was normal and levels of global DNA damage were inconsistent between cell types, DNA damage may contribute differently to the pathology in different tissues. |
format | Online Article Text |
id | pubmed-3328754 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-33287542012-04-18 Dyskeratosis congenita and the DNA damage response Kirwan, Michael Beswick, Richard Walne, Amanda J Hossain, Upal Casimir, Colin Vulliamy, Tom Dokal, Inderjeet Br J Haematol Paediatric Dyskeratosis congenita (DC) is a heterogeneous bone marrow failure disorder with known mutations in components of telomerase and telomere shelterin. Recent work in a mouse model with a dyskerin mutation has implicated an increased DNA damage response as part of the cellular pathology, while mouse models with Terc and Tert mutations displayed a normal response. To clarify how these contradictory results might apply to DC pathology in humans, we studied the cellular phenotype in primary cells from DC patients of several genetic subtypes, focussing on T lymphocytes to remain close to the haematopoietic system. We observed novel cell cycle abnormalities in conjunction with impaired growth and an increase in apoptosis. Using flow cytometry and confocal microscopy we examined induction of the DNA damage proteins γ-H2AX and 53BP1 and the cell cycle protein TP53 (p53). We found an increase in damage foci at telomeres in lymphocytes and an increase in the basal level of DNA damage in fibroblasts, but crucially no increased response to DNA damaging agents in either cell type. As the response to induced DNA damage was normal and levels of global DNA damage were inconsistent between cell types, DNA damage may contribute differently to the pathology in different tissues. Blackwell Publishing Ltd 2011-06 /pmc/articles/PMC3328754/ /pubmed/21477209 http://dx.doi.org/10.1111/j.1365-2141.2011.08679.x Text en © 2011 Blackwell Publishing Ltd http://creativecommons.org/licenses/by/2.5/ Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation. |
spellingShingle | Paediatric Kirwan, Michael Beswick, Richard Walne, Amanda J Hossain, Upal Casimir, Colin Vulliamy, Tom Dokal, Inderjeet Dyskeratosis congenita and the DNA damage response |
title | Dyskeratosis congenita and the DNA damage response |
title_full | Dyskeratosis congenita and the DNA damage response |
title_fullStr | Dyskeratosis congenita and the DNA damage response |
title_full_unstemmed | Dyskeratosis congenita and the DNA damage response |
title_short | Dyskeratosis congenita and the DNA damage response |
title_sort | dyskeratosis congenita and the dna damage response |
topic | Paediatric |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328754/ https://www.ncbi.nlm.nih.gov/pubmed/21477209 http://dx.doi.org/10.1111/j.1365-2141.2011.08679.x |
work_keys_str_mv | AT kirwanmichael dyskeratosiscongenitaandthednadamageresponse AT beswickrichard dyskeratosiscongenitaandthednadamageresponse AT walneamandaj dyskeratosiscongenitaandthednadamageresponse AT hossainupal dyskeratosiscongenitaandthednadamageresponse AT casimircolin dyskeratosiscongenitaandthednadamageresponse AT vulliamytom dyskeratosiscongenitaandthednadamageresponse AT dokalinderjeet dyskeratosiscongenitaandthednadamageresponse |